Type I interferon and TNFα cooperate with type II interferon for TRAIL induction and triggering of apoptosis in SK-N-MC EWING tumor cells

Oncogene

Volumn 23, Issue 28, 2004, Pages 4911-4920

  Abadie, Annie ^a   Besançon, Françoise ^a   Wietzerbin, Juana ^a  

^a INSTITUT CURIE   (France)

Author keywords

Apoptosis; Ewing's sarcoma; IFN ; IFN ; TNF ; TRAIL

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; GAMMA INTERFERON; INTERFERON; MEMBRANE PROTEIN; PRIMER DNA; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIVITY; EWING SARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SUPERNATANT; TUMOR CELL; BIOSYNTHESIS; BONE TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; GENETICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; BONE NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE I; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, EWING'S; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042723617     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207614     Document Type: Article

References (62)

1. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C and Gronemeyer H. (2001). Nat. Med., 7, 680-686.
2. Arvand A and Denny CT. (2001). Oncogene, 20, 5747-5754.
3. Ashkenazi A. (2002). Nature, 2, 420-430.
4. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
5. Aurias A, Rimbaut C, Buffe C, Dubousset J and Mazabraud A. (1983). N. Engl. J. Med., 309, 496-497.
6. Baldwin AS. (2001). J. Clin. Investt., 107, 241-246.
7. Borden EC. (1998). Oncologist, 3, 198-203.
8. Borden EC, Lindner D, Dreicer R, Hussein M and Peereboom D. (2000). Sem. Cancer. Biol., 10, 125-144.
9. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH and Borden EC. (2003). Apoptosis, 8, 237-249.
10. Cheshire JL and Baldwin Jr AS. (1997). Mol. Cell. Biol., 17, 6746-6754.
11. Darnell JE, Kerr IM and Stark G. (1994). Science, 264, 1415-1421.
12. De Alava E and Gerald WL. (2000). J. Clin. Oncol., 18, 204-213.
13. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, De Jong P, Rouleau G, Aurias A and Thomas G. (1992). Nature, 359, 162-165.
14. Fanger NA, Maliszewski CR, Schooley K and Griffith TS. (1999). J. Exp. Med., 190, 1155-1164.
15. Fizazi K, Dohollou N, Blay JY, Guerin S, Le Cesne A, Andre F, Pouillard P, Tursz T and Nguyen BB. (1998). J. Clin. Oncol., 16, 3736-3743.
16. Griffith TS, Chin WA, Jackson GC, Lynch DH and Kubin MZ. (1998). J. Immunol., 161, 2833-2840.
17. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR and Fanger NA. (1999). J. Exp. Med. 189, 1343-1354.
18. Horowitz ME, Malawer MM, Woo SY and Hicks MJ. (1997). Principles and Practice of Pediatric Oncology, Pizzo PA and Poplack DG (eds) Lippincott-Raven Publishers: Philadelphia, pp. 831-863.
19. Javelaud D and Besançon F. (2001). Oncogene, 20, 4365-4372.
20. Javelaud D, Poupon MF, Wietzerbin J and Besançon F. (2002). Int. J. Cancer, 98, 193-198.
21. Javelaud D, Wietzerbin J, Delattre O and Besançon F. (2000). Oncogene, 19, 61-68.
22. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K and Yagita H. (1999). J. Exp. Med., 189, 1451-1460.
23. Kontny HU, Hämmerle K, Klein R, Shayan P, Mackall CL and Niemeyer CM. (2001). Cell Death Differ., 8, 506-514.
24. Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, Thomas G and Gadner H. (1996). Cell. Growth Differ., 7, 429-437.
25. Kretz-Remy C, Munsch B and Arrigo AP. (2001). J. Biol. Chem., 276, 43723-43733.
26. Kumar A, Jasmin A, Eby MT and Chaudhary PM. (2001). Oncogene, 20, 1010-1014.
27. Langaas V, Shahzidi S, Johnsen JI, Smedsrod B and Sveinbjornsson B. (2001). Anticancer Res., 21, 3733-3738.
28. Lawrence D, Shahrokh Z, Marsters S, Masters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge J, Schow P, Hooley J, Sherwood S, Pai R, leling S, Khan L, Gliniak B, Bussiere S, Smith CA, Strom S, kelley S, Fox JA, Thomas D and Ashkenazi A. (2001). Nature, 7, 382-385.
29. Lejeune FJ. (2002). J. Clin. Invest., 110, 433-435.
30. Lienard D, Ewalenko P, Delmotte JJ, Renard N and Lejeune F. (1992). J. Clin. Oncol., 10, 52-60.
31. Lindner DJ and Borden EC. (1997). J. Interferon Cytokine Res., 11, 681-693.
32. Lindner DJ, Borden EC and Kalvakolanu DV. (1997). Clin. Cancer Res., 3, 931-937.
33. Liu SQ, Saijo K, Todoroki T and Ohno T. (1995). Nat. Med., 3, 267-271.
34. Martinez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Pineiro A, Naval J and Anel A. (1998). Eur. J. Immunol., 28, 2714-2725.
35. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R and Denny CT. (1993). Mol. Cell. Biol., 13, 7393-7398.
36. Mitsiades N, Poulaki V, Mitsiades C and Tsokos M. (2001). Cancer Res., 61, 2704-2712.
37. Munoz E, Courtois G, Veschambre P, Jalinot P and Israel A. (1994). J. Virol., 68, 8035-8044.
38. Nesterov A, Ivashchenko T and Kraft AS. (2002). Oncogene, 21, 1135-1140.
39. Oshima K, Yanase N, Ibukiyama C, Yamashina A, Kayagaki N, Yagita H and Mizuguchi J. (2001). Cytokine, 14, 193-201.
40. Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP and Pestka S. (1998). Cancer Res., 58, 2489-2499.
41. Pinkerton CR, Bataillard A, Guillo S, Oberlin O, Fervers B and Philip T. (2001). Eur. J. Cancer, 37, 1338-1344.
42. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A. (1996). J. Biol. Chem., 271, 12687-12690.
43. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M and Remacle J. (2001). Nucleic Acids Res., 29, E21 1-5.
44. Rodriguez-Galindo C, Spunt SL and Pappo AS. (2003). Med. Pediatr. Oncol., 40, 276-287.
45. Sanceau J, Hiscott J, Delattre O and Wietzerbin J. (2000). Oncogene, 19, 3372-3383.
46. Sanceau J, Poupon MF, Delattre O, Sastre-Garau X and Wietzerbin J. (2002). Oncogene, 21, 7700-7709.
47. Shankar AG, Ashley S, Craft AW and Pinkerton CR. (2003). Med. Pediatr. Oncol., 40, 141-147.
48. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ and Park JH. (2001). Int. J. Cancer, 93, 262-268.
49. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N and Fidler IJ. (1995). Proc. Natl. Acad. Sci. USA, 92, 4562-4566.
50. Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD. (1998). Annu. Rev. Biochem., 67, 227-264.
51. Suk K, Chang I, Kim YH, Kim S, Kim J Y, Kim H and Lee MS. (2001a). J. Biol. Chem., 276, 13153-13159.
52. Suk K, Kim YH, Chang I, Kim JY, Choi YH, Lee KY and Lee MS. (2001b). FEBS Lett., 495, 66-70.
53. Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN and Harrington Jr WJ. (2001). Oncogene, 20, 7029-7040.
54. Tracey KJ and Cerami A. (1994). Annu. Rev. Med., 45, 491-503.
55. Van Valen FV, Fulda S, Truckenbrod B, Eckervogt V, Sonnemann J, Hillmann A, Rödl R, Hoffmann C, Winkelmann W, Schäfer L, Dockorn-Dworniczak B, Wessel T, Boos J, Debatin KM and Jürgens H. 2000)). Int. J. Cancer, 88, 252-259.
56. Van Valen F, Winkelmann W, Burdach S, Göbel U and Jürgens H. (1993). J. Cancer. Res. Clin. Oncol., 119, 615-621.
57. Wadler S and Schwartz EL. (1997). Oncologist, 2, 254-267.
58. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG and Rauch CT. (1997). EMBO J., 16, 5386-5397.
59. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
60. Wandinger KP, Lünemann JD, Wengert O, Bellmann-Strobi J, Aktas O, Weber A, Grundström E, Ehrlich S, Wernecke KD, Volk HD and Zipp F. (2003). Lancet, 361, 2036-2043.
61. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA and Goodwin RG. (1995). Immunity, 3, 673-682.
62. Zhang C, Ao Z, Seth A and Schlossman SF. (1996). J. Immunol., 157, 3980-3987.